Pen insulin syringes have obvious advantages over traditional syringes

Pen insulin syringe is a product that combines the injection preparation and the syringe into one, because of its accurate dose setting, simple operation, easy to carry, suitable for home use, and avoids the danger of accidentally breaking the syringe when using a glass syringe injection, and is widely used in insulin therapy for diabetic patients, growth hormone therapy for patients with short stature and other fields
.

As protein and peptide drugs receive more and more attention, they have more and more broad application prospects and are more and more widely
used.

The concept of pen insulin syringes was born at the end of the 20th century, named because of its pen-shaped appearance, mainly for the injection of insulin, also known as insulin pens or injection pens
.

Injection pens, which typically consist of a cap, refill, body and needle, are safer, more convenient and more precise
in controlling the dose than traditional glass syringes.

According to whether the refill can be replaced, it is divided into multiple use of pen syringes and one-time use of pen syringes (i.
e.
pre-filled syringes
).

The difference between the two is that the former can be used for a long time (as long as the injection "refill" is changed frequently); The latter can only be discarded after use and is a disposable product
.

Due to the ease of use of pen insulin syringes, they have made great strides in some national markets, especially in the field of
insulin formulations.

According to foreign information media reports, about 80% of diabetics in Europe currently use it to control blood sugar, and about 75% of diabetics in Japan use it
.

As far as the domestic situation is concerned, the patient awareness rate and treatment rate of many diseases are still relatively low, and there is huge room
for improvement.

At the same time, aging and changes in the disease spectrum are also increasing the number of patient groups
.

The above reasons determine that China's market still has huge potential space
.

Take diabetes, for example
.

According to the data, about 2 million people between the ages of 20 and 79 died of diabetes
in 2017.

Diabetes is also one
of the larger areas of medication due to the need for lifelong medication.

According to the data, there are about 114 million diabetic patients in China, and the prevalence rate is as high as 11.
6%.


The new cross-sectional survey of diabetes shows that as of 2013, the awareness rate and treatment rate of diabetic patients were only 1/3, while the control rate was less than 50%, which is still at a low level
.